# Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)

> **NCT05106413** · NA · TERMINATED · sponsor: **Sonova AG** · enrollment: 23 (actual)

## Conditions studied

- Hearing Loss

## Interventions

- **OTHER:** BiCROS fitting
- **OTHER:** Monaural fitting
- **OTHER:** Unaided condition
- **OTHER:** CROS baseline

## Key facts

- **NCT ID:** NCT05106413
- **Lead sponsor:** Sonova AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-26
- **Primary completion:** 2022-03-14
- **Final completion:** 2022-03-14
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** This clinical trial has been early terminated due to recruiting issues of the calculated sample size.
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05106413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05106413, "Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05106413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*